Volume 31, Number 2—February 2025
Research
Cyclospora Genotypic Variations and Associated Epidemiologic Characteristics, United States, 2018–2021
Figure 2

Figure 2. Proportion of Cyclospora cayetanensis and C. ashfordi in 7 states with highest number of specimens in study of Cyclospora genotypic variations and associated epidemiologic characteristics United States, 2018–2021. A) New York; B) Texas; C) Florida; D) Illinois; E) Iowa; F) Wisconsin; G) Minnesota. No specimens were submitted for genotyping from Florida in 2018 or from Iowa in 2021.
1These senior authors were co–principal investigators.
Page created: December 30, 2024
Page updated: January 31, 2025
Page reviewed: January 31, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.